Quell Therapeutics Limited
Quell Therapeutics Limited
Explore linked clinical trials.3 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Controlling Hyperactive Immunity With Long-lived Lymphocytes | Skin and Connective Tissue Diseases, arthritic joint disease, arthropathy, autoimmune disease, connective tissue disorder, diffuse scleroderma, immune system disorder, musculoskeletal system disorder, rheumatic disorder, rheumatoid arthritis, skin disorder, systemic sclerosis | Recruiting | Phase 1 / Phase 2 | 2026-08-21 | NCT07473154 | |
| Safety and Clinical Activity of QEL-001 in A2-mismatch Liver Transplant Patients | Digestive System Diseases, Hepatic Insufficiency, liver disorder, liver failure | Active, not recruiting | Phase 1 / Phase 2 | 2026-07-02 | NCT05234190 | |
| Prospective Study of White Blood Cells | Inflammation, Pathologic Processes, Pathological Conditions, Signs and Symptoms, autoimmune disease, immune system disorder | Recruiting | Not stated | 2026-01-21 | NCT04838171 |